Evidence map›Paper›PMID 29058722›Full record

ArticleNature methods2017

Deciphering lipid structures based on platform-independent decision rules.

Jürgen Hartler, Alexander Triebl, Andreas Ziegl, Martin Trötzmüller, Gerald N Rechberger, Oana A Zeleznik, Kathrin A Zierler, Federico Torta, Amaury Cazenave-Gassiot, Markus R Wenk and 10 more

Abstract read
In one paragraph

Article in Nature methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Lipid and Metabolite Annotation Using Lipid Data Analyzer.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jürgen HartlerInstitute of Computational Biotechnology, Graz University of Technology, Graz, Austria.ORCID http://orcid.org/0000-0002-1095-6458
Alexander TrieblCenter for Medical Research, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-8423-8224
Andreas ZieglInstitute of Computational Biotechnology, Graz University of Technology, Graz, Austria.
Martin TrötzmüllerCenter for Medical Research, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-0545-9892
Gerald N RechbergerOmics Center Graz, BioTechMed-Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-0071-317X
Oana A ZeleznikChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Kathrin A ZierlerDepartment of Molecular Biosciences, University of Graz, Graz, Austria.
Federico TortaSingapore Lipidomics Incubator, National University of Singapore, Singapore.
Amaury Cazenave-GassiotSingapore Lipidomics Incubator, National University of Singapore, Singapore.ORCID http://orcid.org/0000-0002-3050-634X
Markus R WenkSingapore Lipidomics Incubator, National University of Singapore, Singapore.
Alexander FaulandDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Craig E WheelockDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8113-0653
Aaron M ArmandoSchool of Medicine, University of California San Diego, La Jolla, California, USA.
Oswald QuehenbergerSchool of Medicine, University of California San Diego, La Jolla, California, USA.
Qifeng ZhangThe Babraham Institute, Babraham Research Campus, Cambridge, UK.
Michael J O WakelamThe Babraham Institute, Babraham Research Campus, Cambridge, UK.
Guenter HaemmerleDepartment of Molecular Biosciences, University of Graz, Graz, Austria.
Friedrich SpenerDepartment of Molecular Biosciences, University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-3507-6983
Harald C KöfelerCenter for Medical Research, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-2725-9616
Gerhard G ThallingerInstitute of Computational Biotechnology, Graz University of Technology, Graz, Austria.ORCID http://orcid.org/0000-0002-2864-5404

Funding

Austrian Science Fund FWF P 26148Biotechnology and Biological Sciences Research Council BBS/E/B/000C0413Biotechnology and Biological Sciences Research Council BBS/E/B/000C0415Biotechnology and Biological Sciences Research Council BBS/E/B/000C0419
6 · The paper itself

Abstract

We achieve automated and reliable annotation of lipid species and their molecular structures in high-throughput data from chromatography-coupled tandem mass spectrometry using decision rule sets embedded in Lipid Data Analyzer (LDA; http://genome.tugraz.at/lda2). Using various low- and high-resolution mass spectrometry instruments with several collision energies, we proved the method's platform independence. We propose that the software's reliability, flexibility, and ability to identify novel lipid molecular species may now render current state-of-the-art lipid libraries obsolete.

Indexed as

AlgorithmsAnimalsChromatography, LiquidLipidsLiverMiceMolecular StructureReproducibility of ResultsSensitivity and SpecificityTandem Mass SpectrometryLipids

Identifiers

PMID29058722
PMCPMC5988032

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.